ALLMedicine™ Alopecia Center
Research & Reviews 3,080 results
JAMA Dermatology; Chen V, Akhtar S et. al.
Jan 27th, 2022 - Although there have been increased efforts in dermatologic research to improve representation of patient sex, race, and ethnicity, there are limited data evaluating resulting changes. To characterize the diversity of participants in dermatologic c...
International Journal of Dermatology; Verschoore M, Dlova N
Jan 27th, 2022 - Highly pigmented African skin and hair have distinct characteristics because of their unique physiology and structure. Twenty years ago, despite an increasing number of dermatology specialists in some African countries, there remained a paucity of...
Journal of the American Academy of Dermatology; Maghfour J, Ceresnie M et. al.
Jan 26th, 2022 - The Association between Frontal Fibrosing Alopecia, Sunscreen, and Moisturizers: A Systematic Review with a Meta-Analysis.|2022|Maghfour J,Ceresnie M,Olson J,Lim HW,|
The American Journal of Dermatopathology; Frew D, Oaxaca G et. al.
Jan 26th, 2022 - Lichen planopilaris (LPP) is a scarring alopecia that is characterized by a lichenoid interface infiltrate with follicular extension. We present a case of LPP composed predominantly of plasma cells in a 52-year-old man. The patient was originally ...
The Journal of Investigative Dermatology; Cui J, Zhao Q et. al.
Jan 24th, 2022 - Kelch-like protein 24 (KLHL24) is an E3 ubiquitin ligase. Mutations in the start codon of KLHL24 result in truncated KLHL24 protein lacking the initial 28 amino acids (KLHL24-ΔN28). KLHL24-ΔN28 is more stable than wide-type KLHL24 and causes exces...
Guidelines 3 results
The Journal of Dermatology; Manabe M, Tsuboi R et. al.
Jun 5th, 2018 - Male-pattern hair loss (MPHL, androgenetic alopecia) is a slowly progressive form of alopecia which begins after puberty. In 2010, we published the first Japanese edition of guidelines for the diagnosis and treatment of MPHL. It achieved the origi...
Journal of the European Academy of Dermatology and Venere... Lee WS, Lee HJ et. al.
Nov 28th, 2012 - Androgenetic alopecia (AGA), or pattern hair loss, is a common disorder in both Asian men and women. There are several guidelines for the treatment of AGA which are suitable for Caucasian patients; however, each of these has some limitations. Furt...
The British Journal of Dermatology; Messenger AG, McKillop J et. al.
Apr 25th, 2012 - British Association of Dermatologists' guidelines for the management of alopecia areata 2012.|2012|Messenger AG,McKillop J,Farrant P,McDonagh AJ,Sladden M,|diagnosis,etiology,therapy,methods,therapeutic use,methods,methods,methods,
Drugs 270 results see all →
Clinicaltrials.gov 139 results
Jan 21st, 2022 - The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to severe alopecia areata.
Jan 21st, 2022 - Each individual will be enrolled in the study for 24 weeks. Following a 28 days screening period, eligible subjects will be randomized in a 1:1 ratio to receive either crisaborole 2% ointment or matching placebo for 12 weeks. The primary endpoint ...
Jan 21st, 2022 - The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to severe alopecia areata. Patients from European sites who p...
Jan 20th, 2022 - Scalp cooling using cooling caps has been identified as an effective treatment option against CT-induced alopecia in numerous European countries. Originally, crashed ice was used to cause vasoconstriction and consequently diminish CT uptake to hai...
Jan 18th, 2022 - PRIMARY OBJECTIVES: I. To determine, in terms of progression-free survival (PFS), the extent of clinical benefit of the addition of adjuvant radiotherapy (RT) to gross total resection (GTR) for patients with newly diagnosed World Health Organizati...
News 565 results
Jan 20th, 2022 - Kevin Kalinsky, MD, MS: Let’s move along with this case. Her treatment course was complicated when she started to experience peripheral neuropathy, and she completed 9 of 14 cycles. Komal, how often do you feel like you see this in practice? Ko...
Jan 3rd, 2022 - The European Medicines Agency (EMA) has validated the Type II Variation application for fam-trastuzumab deruxtecan-nxki (Enhertu) as a treatment for adult patients with unresectable or metastatic HER2-positive breast cancer who have previously rec...
Dec 30th, 2021 - NEW YORK (Reuters Health) - Treatment with the investigational oral Janus kinase (JAK) inhibitors ritlecitinib or brepocitinib led to molecular and clinical improvement in scalp lesions in patients with alopecia areata enrolled in a biopsy sub-stu...
Dec 21st, 2021 - A supplemental new drug application (sNDA) has been submitted to Japan’s Ministry of Health, Labour, and Welfare (MHLW) for the use of fam-trastuzumab deruxtecan-nxki (Enhertu) as a treatment in patients with HER2-positive unresectable or recurren...
Jack Lee, MD, Richard H. Flowers, MD
Dec 14th, 2021 - THE DIAGNOSIS: Vegetative Majocchi Granuloma A biopsy and tissue culture showed acute dermal inflammation with granulomatous features and numerous fungal hyphae within the stratum corneum (Figure 1A), which were confirmed on GrocottGomori methenam.